Vor Biopharma VOR
NASDAQ VOR
$18.94 -0.09 (-0.47%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vor Biopharma (VOR) Ending Cash Balance (2020 - 2025)

Updated

Analysis

Vor Biopharma (VOR) Ending Cash Balance (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.42 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.57 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.03 Bn
10 Vor Biopharma 1.03 Bn -553.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 396.65 Mn
Dec 31, 2024 84.36 Mn
Dec 31, 2023 33.77 Mn
Dec 31, 2022 60.12 Mn
Dec 31, 2021 122.21 Mn
Mar 31, 2021 264.13 Mn
Dec 31, 2020 50.10 Mn
Mar 31, 2020 19.16 Mn
API Access

Vor Biopharma Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=VOR&period=max&api_key=YOUR_API_KEY